Related references
Note: Only part of the references are listed.Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism
Michela Giustozzi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2023)
Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase
Wayneho Kam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects
Wenzhu Li et al.
CIRCULATION (2021)
Effects of the chymase inhibitor fulacimstat in diabetic kidney disease-results from the CADA DIA trial
Peter Rossing et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Pulmonary embolism and deep vein thrombosis: Similar but different
Nicolas Wenger et al.
THROMBOSIS RESEARCH (2021)
Updates in Anticoagulation Therapy Monitoring
Hannah L. McRae et al.
BIOMEDICINES (2021)
Emerging mechanisms contributing to mast cell-mediated pathophysiology with therapeutic implications
Guido H. Falduto et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism A Systematic Review and Meta-analysis
Faizan Khan et al.
ANNALS OF INTERNAL MEDICINE (2021)
Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors
Gunnar Pejler
JOURNAL OF INNATE IMMUNITY (2020)
Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice
Kentaro Terai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Reversal agents for oral anticoagulant-associated major or life-threatening bleeding
Marco Moia et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial
Hans-Dirk Duengen et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Pharmacokinetics, Safety, and Tolerability of the Novel Chymase Inhibitor BAY 1142524 in Healthy Male Volunteers
Friederike Kanefendt et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
Ryan N. Rys et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Prevention of Deep Vein Thrombosis and Pulmonary Embolism in High-Risk Medical Patients
Megan McCullough et al.
CLINICS IN CHEST MEDICINE (2018)
Venous Thromboembolism Advances in Diagnosis and Treatment
Tobias Tritschler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Mast cell hyperactivity underpins the development of oxygen-induced retinopathy
Kenshiro Matsuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
Holly Payne et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Mast Cells Granular Contents Are Crucial for Deep Vein Thrombosis in Mice
Tatyana Ponomaryov et al.
CIRCULATION RESEARCH (2017)
Platelet amyloid precursor protein is a modulator of venous thromboembolism in mice
Ilaria Canobbio et al.
BLOOD (2017)
Mast cell proteases as pharmacological targets
George H. Caughey
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
New approaches in tail-bleeding assay in mice: improving an important method for designing new anti-thrombotic agents
Max Seidy Saito et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2016)
Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction
Anta Ngkelo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs
Scott D. Grosse et al.
THROMBOSIS RESEARCH (2016)
Mast Cell: A Multi-Functional Master Cell
Melissa Krystel-Whittemore et al.
FRONTIERS IN IMMUNOLOGY (2016)
Venous return and clinical hemodynamics: how the body works during acute hemorrhage
Tao Shen et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2015)
Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase
Walid Semaan et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Fibrinolysis and the control of blood coagulation
John C. Chapin et al.
BLOOD REVIEWS (2015)
Endothelial cell control of thrombosis
Jonathan W. Yau et al.
BMC CARDIOVASCULAR DISORDERS (2015)
Epidemiology of venous thromboembolism
John A. Heit
NATURE REVIEWS CARDIOLOGY (2015)
Hypoxia Induces a Prothrombotic State Independently of the Physical Activity
Marisa Ninivaggi et al.
PLOS ONE (2015)
Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem
Mitchell J. Daley et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2015)
Mast Cells as Effectors in Atherosclerosis
Ilze Bot et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Mast Cell Function: A New Vision of an Old Cell
Elaine Zayas Marcelino da Silva et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson et al.
LANCET (2014)
Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events
Sanne Willems et al.
EUROPEAN HEART JOURNAL (2013)
Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl3-induced occlusive thrombus formation in the inferior vena cava of mice
M. V. Joglekar et al.
PLATELETS (2013)
Critical Review of Mouse Models of Venous Thrombosis
Jose A. Diaz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
In vivo monitoring of venous thrombosis in mice
M. N. Aghourian et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Physical Characterization of Mouse Deep Vein Thrombosis Derived Microparticles by Differential Filtration with Nanopore Filters
Antonio Peramo et al.
MEMBRANES (2012)
α2-Macroglobulin Capture Allows Detection of Mast Cell Chymase in Serum and Creates a Reservoir of Angiotensin II-Generating Activity
Wilfred W. Raymond et al.
JOURNAL OF IMMUNOLOGY (2009)
Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats
Suresh S. Palaniyandi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Mast cells: multipotent local effector cells in atherothrombosis
Petri T. Kovanen
IMMUNOLOGICAL REVIEWS (2007)
A role for cardiac mast cells in the pathogenesis of hypertensive heart disease
N Shiota et al.
JOURNAL OF HYPERTENSION (2003)
The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue.: A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover
E Tchougounova et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice
E Kakizoe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Share Paper
